Skip to main content
. 2022 Oct 26;13(45):13489–13498. doi: 10.1039/d2sc04072g

Residues identified in the interface interaction site as identified by PyLipID. All residues with occupancy of >40% are listed. Note that the yeast supercomplex, due to having two CIV monomers, also has two interface interaction sites.

Species Lipid Residues
Yeast CL Site 1: CIII: Rieske subunit: K44, K51; Sub8: K35; Sub9: S2, F3, S4, S5
CIV: COX5A: S93, F94, K97
Site 2: CIII: Rieske subunit: K44, K51, Y55; Sub8: K35, P36, L37; Sub9: S2, S4, S5
CIV: COX5A: S93, K97
MLCL Site 1: CIII: Rieske subunit: K44, N46, K51; Sub8: K35
CIV: COX1: K408; COX5A: G90, S93, K97
Site 2: CIII: Rieske subunit: K44, N46, K51, Y55; Sub8: K35, P36, L37, Q38, H42
CIV: COX5A: G90, S92, S93, F94, K97
Mouse CL CIII: Sub8: R24, F26, S28, S31
CIV: COX7A2L: S54, G55, K56; COX3: R156, N157, H158, Q161, L223; COX5B: S3; COX6A2: R17
MLCL CIII: Sub8: R24, S31
CIV: COX7A2L: Y53, S54, G55, K56; COX3: R156, N157, H158, N160, L223; COX5B: S3
Human CL CIII: Rieske subunit: R93, F113; Sub4: T305, H309; Sub8: R25, A26, Y27, P28, H29, V30, T32
CIV: COX3: N157, Q158; COX5B: A32; COX6A1: R36, K39
MLCL CIII: Rieske subunit: R93, F113; Sub4: T305, H309; Sub8: R25, A26, Y27, P28, H29, V30, T32
CIV: COX3: N157, Q158, Q161; COX5B: A32; COX6A1: R36, K39